NORGES BANK - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 21 filers reported holding EFFECTOR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
NORGES BANK ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$591,146
-64.6%
416,3000.0%0.00%
Q1 2022$1,669,363416,3000.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$27,357,00014.00%
Abingworth LLP 4,822,114$18,903,0005.36%
Column Group LLC 4,309,329$17,280,0003.20%
OUP Management Co., LLC 1,025,697$4,113,0003.13%
SECTORAL ASSET MANAGEMENT INC 2,382,744$9,555,0001.70%
Parallel Advisors, LLC 677,452$2,744,0000.11%
Oasis Management Co Ltd. 100,000$401,0000.06%
Blackstone Inc. 1,308,587$5,248,0000.01%
ALPS ADVISORS INC 46,537$187,0000.00%
Tower Research Capital LLC (TRC) 548$2,0000.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders